Semaglutide + BPC-157 a weight loss game changer.
FDA approved glucagon-like peptide Studies have demonstrated that Semaglutide reduces appetite, improved control of eating, and reduced food cravings in addition to improved glycemic control.
BPC-157 stands for Body Protection Compound 157, a peptide chain. It helps decrease intestinal damage and inflammation. (AKA leaky gut)
In a clinical trial, participants taking semaglutide lost 15 percent of their body weight, on average. Those who got the drug lost close to 15 percent of their body weight, on average, compared with 2.4 percent among those receiving a placebo. And it is expected that patients would have to take it for a lifetime to prevent the weight loss from coming back.— The New York Times 10/26/21, 10:23 AM Semaglutide Brings Significant Weight Loss in Obese Patients